As Lentiviral vectors have transformed medicine with their safety and efficacy, they have created a demand for production that far exceeds current capacity.

Traditional manufacturing systems have seen long wait times and critical raw material shortages cause delays in development and deployment of these life-altering therapies.

Our Intelligent Vector Solutions(TM) can be used to manufacture ANY LENTI, ANY SCALE(TM) to provide our clients an END TO END solution, speeding their development and securing their supply chain.

Biotechnology

iVexSol

The Lexington office focuses on scientific research and development, particularly in analytical and cellular mechanisms.

Lexington

iVexSol's headquarters in New York, NY, United States

Vikram Sarveiya

Joe Gentile

Kenneth Locke

Ian Smith

The Scientific Research Team at iVexSol is dedicated to advancing the development and manufacturing of lentiviral vectors. They conduct cutting-edge research to optimize viral vector production processes, ensuring scalability and efficiency. By leveraging their expertise, the team supports the innovation of Intelligent Vector Solutions(TM) that meet the high demands of the biopharmaceutical industry, ultimately accelerating the delivery of life-changing therapies.

iVexSol

Org chart

Board & advisors

Teams

Scientific Research Team

Offices

iVexSol

Org chart

Board & advisors

Teams

Scientific Research Team

Offices

Related companies